COVID-19 vaccine benefits exaggerated, say experts

Source: https://maryannedemasi.com/publications/f/covid-19-vaccine-benefits-exaggerated-say-experts

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK

Study: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2932661-1

By Maryanne Demasi, PhD

In February, Federal Health Minister Greg Hunt boasted that AstraZeneca’s COVID-19 vaccine offered “100% protection” against death in the primary analysis of phase III trials. 

It was repeated by the CEO of AstraZeneca and uncritically reported by the mainstream media in what seemed to be an impressive achievement.

The published study in The Lancet, however, revealed a more nuanced picture. 

In the trial of 23,848 subjects across the UK, Brazil, and South Africa, there was one death in the placebo group and no deaths in the vaccinated group. 

One less death out of a total of one, indeed, was a relative reduction of 100% but the absolute reduction was 0.01%. (1/11,724 – 0/12,021)

Similarly, in February the CDC director Rochelle Walensky co-authored a publication in JAMA, which stated unequivocally:

“Clinical trials have shown that the vaccines authorized for use in the US are highly effective against COVID-19 infection, severe illness, and death.” 

However, there were too few deaths recorded in the controlled trials at the time to arrive at such a conclusion.  

The 6 month follow up data from the blinded Pfizer trial found there were 15 deaths in the vaccine group and 14 deaths in the placebo group. (see table S4)

Last week, at a roundtable meeting in the US Capitol, Prof Peter Doshi, associate editor of The BMJ raised concerns about the statements made by the CDC director.

Vaccine News – Natural Herbal HPV “Cure” Discovered with study

Subcutaneous injections of aluminum at vaccine adjuvant levels activate innate immune genes in mouse brain that are homologous with biomarkers of autism

Highlights
• Mechanisms underlying aluminum adjuvant neurotoxicity have been investigated.
• Key proinflammatory factors were found elevated in the brains of aluminum-injected mice.
• Male mice were more susceptible to aluminum’s neuroinflammatory effects than females.
• Frontal cortex was the most affected area in males.
• Frontal cortex is involved in emotional and social functions which are impaired in autism.

Abstract
Autism is a neurobehavioral disorder characterized by immune dysfunction. It is manifested in early childhood, during a window of early developmental vulnerability where the normal developmental trajectory is most susceptible to xenobiotic insults. Aluminum (Al) vaccine adjuvants are xenobiotics with immunostimulating and neurotoxic properties to which infants worldwide are routinely exposed. To investigate Al′s immune and neurotoxic impact in vivo, we tested the expression of 17 genes which are implicated in both autism and innate immune response in brain samples of Al-injected mice in comparison to control mice. Several key players of innate immunity, such as cytokines CCL2, IFNG and TNFA, were significantly upregulated, while the nuclear factor-kappa beta (NF-κB) inhibitor NFKBIB, and the enzyme controlling the degradation of the neurotransmitter acetylcholine (ACHE), were downregulated in Al-injected male mice. Further, the decrease of the NF-κB inhibitor and the consequent increase in inflammatory signals, led to the activation of the NF-κB signaling pathway resulting in the release of chemokine MIP-1A and cytokines IL-4 and IL-6. It thus appears that Al triggered innate immune system activation and altered cholinergic activity in male mice, observations which are consistent with those in autism. Female mice were less susceptible to Al exposure as only the expression levels of NF-κB inhibitor and TNFA were altered. Regional patterns of gene expression alterations also exhibited gender differences, as frontal cortex was the most affected area in males and cerebellum in females. Thus, Al adjuvant promotes brain inflammation and males appear to be more susceptible to Al′s toxic effects.

Nagalase Intentionally Put In to Vaccines For Depopulation
Scientists and holistic doctors have recently discovered Nagalase In many different vaccines, which spurs tumor growth by suppressing the bodies Immune system. It Is certain that these Nagalase molecules have been deliberately Inserted In to the vaccines to push up the numbers of people developing cancer, significantly Increasing the pharmaceutical Industry’s cancer drugs profits. Recently 30+ holistic doctors have been murdered for discovering nagalase In vaccines, healthy children have been found to have had high levels of this In their bodies, most likely administered through Injections. Nagalase Inhibits GcMAF.
One of the doctors that discovered the link between GcMAF and how It fights disease, was using this to treat his cancer patients, he died on On June 19, 2015, Dr. Jeff Bradstreet who apparently shot himself, was almost certainly murdered by the Cabal of criminals who are behind this conspiracy.
Human GcMAF holds great promise in the treatment of various illnesses including cancer, autism, chronic fatigue and possibly Parkinson’s. Since 1990, 59 research papers have been published on GcMAF, 20 of these pertaining to the treatment of cancer.
Dr Bradstreet was an alternative autism specialist and is widely regarded as a pioneer in the naturopathic field. He was using GcMAF and successfully treating dying cancer patients. To understand what put him on the deadly radar of the U.S. FDA and the pharmaceutical companies was that GcMAF has shown the ability to completely reverse autism and cancer without the use of chemotherapy, radiation, or surgery.

I am 100% anti-vaccine, with no exceptions. A moratorium on vaccines must take place, and until the CDC can directly answer under oath as to what has gone on. There needs to be Nuremberg Code violation trials as a result of that investigation. The corrupt now since 1987, federal vaccine court needs to be abolished, and pharma and the vaccine providers need again to become accountable and legally liable for the vaccine injury and death harm that is done. They refuse to see and to admit to what they have done. They are in lying and complete denial, and they continue to quake for their jobs and their false monopoly authority and their military style mafia level control.
Lowell Hubbs

Natural Herbal HPV “Cure” Discovered
Posted on: Monday, March 10th 2014 at 5:00 am
Written By: Sayer Ji, Founder

Despite the widespread belief that HPV infection is a lethal force against which we only have vaccination and watchful waiting to defend ourselves, both ancient herbal medicine and our body’s inherent immune defenses have newly been confirmed to have significant power against it.
A groundbreaking study published in the Asian Pacific Journal of Cancer Prevention, titled, “Clearance of Cervical Human Papillomavirus Infection by Topical Application of Curcumin and Curcumin Containing Polyherbal Cream: A Phase II Randomized Controlled Study,” reveals that vaccination and watchful waiting are not the only recourse against HPV infection.
The study is believed to be the first of its kind to find an effective and safe therapeutic intervention for the clearance of established cervical human papillomavirus (HPV) infection. Moreover, the study confirmed that HPV infection is self-limiting and clears on its own in 73.3% of the untreated placebo group within 37 days.
The researchers evaluated the effectiveness of two herbal interventions in eliminating HPV infection from the cervix of women who were determined to have HPV infection through Pap smear and HPV DNA tests (PCR), but whose condition had not yet progressed to high grade cervical neoplasias (i.e. cervical pre-cancer).
The first intervention used was a polyherbal vaginal cream containing containing extracts of curcumin, reetha, amla and aloe vera, known by the trade name Basant. The second intervention was a curcumin vaginal capsule. The other two placebo groups received either a vaginal placebo cream or a placebo vaginal capsule.
All 287 subjects were instructed to use one application of the assigned formulation daily for 30 consecutive days except during menstruation. Seven days after the last application they were recalled for repeat HPV test, cytology and colposcopy.
The results were reported as follows:
“HPV clearance rate in Basant arm (87.7%) was significantly higher than the combined placebo arms (73.3%). Curcumin caused higher rate of clearance (81.3%) than placebo though the difference was not statistically significant.”
Vaginal irritation and itching, mostly mild to moderate, was significantly higher after Basant application. No serious adverse events were noted.

Clearance of Cervical Human Papillomavirus Infection by Topical Application of Curcumin and Curcumin Containing Polyherbal Cream: A Phase II Randomized Controlled Study
Article 31, Volume 14, Issue 10, October 2013, Page 5753-5759

Abstract
Curcumin and curcumin containing polyherbal preparations have demonstrated anti-microbial and antiviralproperties in pre-clinical studies. Till date no therapeutic intervention has been proved to be effective andsafe in clearing established cervical human papillomavirus (HPV) infection. The present study evaluated theefficacy of Basant polyherbal vaginal cream (containing extracts of curcumin, reetha, amla and aloe vera) andof curcumin vaginal capsules to eliminate HPV infection from cervix. Women were screened by Pap smear andHPV DNA test by PCR. HPV positive women without high grade cervical neoplasias (N=287) were randomizedto four intervention arms to be treated with vaginal Basant cream, vaginal placebo cream, curcumin vaginalcapsules and placebo vaginal capsules respectively. All subjects were instructed to use one application of theassigned formulation daily for 30 consecutive days except during menstruation and recalled within seven daysof the last application for repeat HPV test, cytology and colposcopy. HPV clearance rate in Basant arm (87.7%)was significantly higher than the combined placebo arms (73.3%). Curcumin caused higher rate of clearance(81.3%) than placebo though the difference was not statistically significant. Vaginal irritation and itching, mostlymild to moderate, was significantly higher after Basant application. No serious adverse events were noted.

Raila joins Catholic Church in opposing tetanus vaccine
Monday September 11 2017
The opposition on Monday re-ignited an unresolved controversial topic when its presidential candidate Raila Odinga claimed that the government administered tetanus vaccine secretly laced with a hormone said to cause infertility in women.
Mr Odinga claimed that the government deliberately sterilised thousands of women and girls in the guise of tetanus vaccination.
He further claimed that four credible institutions had conducted independent tests on the vaccine, which showed that it had compounds with high amount of anti-pregnancy hormone called human chorionic gonadotropin (hCG) that would render the women and girls sterile.

CONFLICT
But then Health Cabinet Secretary James Macharia disputed the claims and told BBC that the vaccine was safe.
“I would recommend my own daughter and wife to take it because I entirely 100 percent agree with it and have confidence that it has no adverse health effects,” Mr Macharia said.
The tangle between the church and the government began on March 2014 when bishops became suspicious about the vaccine, which was targeted at women in the reproductive ages of 14 to 49, and excluded boys and men.

RESULTS
The controversy culminated in the formation of a joint committee of experts from the government and the Church, which was co-chaired by Prof Fredrick Were from the ministry and Dr Stephen Karanja representing the Church.
But months after the joint testing, the company hired to test the samples —Agriq Quest Ltd — in a damning letter claimed that the ministry through its then Principal Secretary Nicholas Muraguri wanted the results altered.

Mercury and Aluminum in Vaccines: a Primer on NVIC’s Vaccine Ingredients Calculator
Posted on January 30, 2012
by Marcella Piper-Terry, M.S.
This article will tell you how to recognize the symptoms of aluminum toxicity. Aluminum toxicity is something I am very concerned about. In 2004, a large portion of the mercury that was previously used in childhood vaccines was removed from those sold and administered in the United States.
Many people, including many physicians, believe and will tell you “There is no mercury in vaccines anymore. They took that out years ago!” This is not true. For a list of vaccines that still contain mercury above EPA safety levels click here: http://www.vaccinesafety.edu/components-Excipients.htm
Seven vaccines are reported to still contain thimerosal, which is 49.5% mercury.
The statement that there is no thimerosal in vaccines anymore is usually made by those attempting to make the claim that there is no link between autism and vaccines. These folks will frequently say things like, “They removed mercury from the shots and the autism rate has continued to go up! That proves vaccines don’t cause autism!”

All 8 extreme childhood food allergies are also common ingredients in CDC-recommended vaccines… coincidence?
Monday, September 18, 2017 by: S.D. Wells
(Natural News) Food allergy awareness posters in elementary schools list the following 8 food products as the most popular food allergies among children. Allergic reactions from exposure, consumption or injection of these foods can be fatal. Those 8 ingredients include peanuts, nuts, wheat, soy, milk, eggs, fish and shellfish. If your M.D. tells you that your food allergies are hereditary, maybe that’s because your parents were injected with the same food “excipients” when they got their dozens of vaccines growing up. Either you inherited your parent’s allergies, or millions of humans are simply allergic to injecting proteins, foreign animal blood cells, aborted baby blood cells, known carcinogens, and heavy metal toxins directly into their muscle tissue and blood, which would make perfect sense for any normal person with a perfectly functioning immune system.

 

Vitamin D supplementation improves autism in children, according to new study

Vitamin D supplementation improves autism in children, according to new study
Furthermore, children who received vitamin D supplementation experienced  increased cognitive awareness, social awareness and social cognition compared to those who only received the placebo. Vitamin D supplementation significantly decreased repetitive hand movements, random noises, jumping and restricted interests.
The researchers concluded,
“This study is the first double-blinded RCT proving the efficacy of vitamin D3 in ASD patients…Oral vitamin D supplementation may safely improve signs and symptoms of ASD and could be recommended for children with ASD.”
The study also mentioned that the supplementation regimen was well tolerated among the children. Only five children experienced minor side effects during the four-month study period, such as skin rashes, itching and diarrhea.

Study – Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.
RESULTS:
Supplementation of vitamin D was well tolerated by the ASD children. The daily doses used in the therapy group was 300 IU vitamin D3/kg/day, not to exceed 5,000 IU/day. The autism symptoms of the children improved significantly, following 4-month vitamin D3 supplementation, but not in the placebo group. This study demonstrates the efficacy and tolerability of high doses of vitamin D3 in children with ASD.
CONCLUSIONS:
This study is the first double-blinded RCT proving the efficacy of vitamin D3 in ASD patients. Depending on the parameters measured in the study, oral vitamin D supplementation may safely improve signs and symptoms of ASD and could be recommended for children with ASD. At this stage, this study is a single RCT with a small number of patients, and a great deal of additional wide-scale studies are needed to critically validate the efficacy of vitamin D in ASD.

Study – Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial
METHODS/DESIGN:
Children with ASD living in New Zealand (n = 168 children) will be randomised to one of four treatments daily: vitamin D (2000 IU), n-3 LCPUFAs (722 mg DHA), vitamin D (2000 IU) + n-3 LCPUFAs (722 mg DHA) or placebo for 12 months. All researchers, participants and their caregivers will be blinded until the data analysis is completed, and randomisation of the active/placebo capsules and allocation will be fully concealed from all mentioned parties. The primary outcome measures are the change in social-communicative functioning, sensory processing issues and problem behaviours between baseline and 12 months. A secondary outcome measure is the effect on gastrointestinal symptoms. Baseline data will be used to assess and correct basic nutritional deficiencies prior to treatment allocation. For safety measures, serum 25-hydroxyvitamin D 25(OH)D and calcium will be monitored at baseline, 6 and 12 months, and weekly compliance and gastrointestinal symptom diaries will be completed by caregivers throughout the study period.
DISCUSSION:
To our knowledge there are no randomised controlled trials assessing the effects of both vitamin D and DHA supplementation on core symptoms of ASD. If it is shown that either vitamin D, DHA or both are effective, the trial would reveal a non-invasive approach to managing ASD symptoms.

Study – Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children
RESULTS:
Fifty-seven percent of the patients in the present study had vitamin D deficiency, and 30% had vitamin D insufficiency. The mean 25-OHD levels in patients with severe autism were significantly lower than those in patients with mild/moderate autism. Serum 25-OHD levels had significant negative correlations with Childhood Autism Rating Scale (CARS) scores. Of the ASD group, 106 patients with low-serum 25-OHD levels (<30 ng/ml) participated in the open label trial. They received vitamin D3 (300 IU/kg/day not to exceed 5000 IU/day) for 3 months. Eighty-three subjects completed 3 months of daily vitamin D treatment. Collectively, 80.72% (67/83) of subjects who received vitamin D3 treatment had significantly improved outcome, which was mainly in the sections of the CARS and aberrant behavior checklist subscales that measure behavior, stereotypy, eye contact, and attention span.
CONCLUSION:
Vitamin D is inexpensive, readily available and safe. It may have beneficial effects in ASD subjects, especially when the final serum level is more than 40 ng/ml.

Study – Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder
Abstract
Objective High prevalence of vitamin D deficiency was previously reported in children with Autism Spectrum Disorder (ASD), but little is known about the efficacy of vitamin D3 treatment in ASD, although data from pilot studies seem promising. We hypothesized that serum vitamin D levels are reduced in ASD and correlate with the severity of disease. Also, we hypothesized that vitamin D3 treatment may be beneficial for a considerable portion of children with ASD. Methods In total, 215 children with ASD and 285 healthy control children were recruited in our study. Thirty seven of 215 ASD children received vitamin D3 treatment. The Autism Behaviour Checklist (ABC) and the Childhood Autism Rating Scale (CARS) were used to assess autism symptoms. High-performance liquid chromatography was used to assess the serum 25-hydroxyvitamin D [25(OH) D] level. Evaluations of ABC, CARS, and serum 25(OH) D levels were performed before and after 3 months of treatment. Results Serum levels of 25(OH) D were significantly lower in ASD children than typically developing children. Levels of serum 25(OH) D were negatively correlated with ABC total scores and language subscale scores. After vitamin D3 supplementation, symptom scores were significantly reduced on the CARS and ABC. In addition, the data also suggest that treatment effects were more pronounced in younger children with ASD. Conclusion Vitamin D deficiency might contribute to the aetiology of ASD. Supplementation of vitamin D3, which is a safe and cost-effective form of treatment, may significantly improve the outcome of some children with ASD, especially younger children (identifier ChiCTR-CCC-13004498). Clinical Trial Registration The trial ‘Association of Polymorphisms of Vitamin D Metabolism-Related Genes With Autism and the Treatment of Autism with Vitamin D’ has been registered at www.chictr.org/cn/proj/show.aspx ? proj=6135 (identifier ChiCTR-CCC-13004498).

Study – Effect of gluten free diet on gastrointestinal and behavioral indices for children with autism spectrum disorders: a randomized clinical trial

Effect of gluten free diet on gastrointestinal and behavioral indices for children with autism spectrum disorders: a randomized clinical trial.
RESULTS:
Of the 80 children, 53.9% had gastrointestinal abnormalities. In the GFD group, the prevalence of gastrointestinal symptoms decreased significantly (P<0.05) after intake of GFD (40.57% vs. 17.10%) but increased insignificantly in the RD group (42.45% vs. 44.05%). GFD intervention resulted in a significant decrease in behavioral disorders (80.03±14.07 vs. 75.82±15.37, P<0.05) but an insignificant increase in the RD group (79.92±15.49 vs. 80.92±16.24).
CONCLUSION:
This study suggested that GFD may be effective in controlling gastrointestinal symptoms and ASD behaviors.

The Alkaline Diet: Is There Evidence That an Alkaline pH Diet Benefits Health?
Abstract
This review looks at the role of an alkaline diet in health. Pubmed was searched looking for articles on pH, potential renal acid loads, bone health, muscle, growth hormone, back pain, vitamin D and chemotherapy. Many books written in the lay literature on the alkaline diet were also reviewed and evaluated in light of the published medical literature. There may be some value in considering an alkaline diet in reducing morbidity and mortality from chronic diseases and further studies are warranted in this area of medicine

Study: Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial

Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial

CONCLUSIONS
In this small trial of children with non-syndromic ASD and language impairment, treatment with high-dose folinic acid for 12 weeks resulted in improvement in measures of verbal communication as compared with placebo. These findings should be considered preliminary until treatment is assessed in larger multicenter studies with longer duration.